The Crystal Mortar Awards (International Drug Chemistry Conference R&D Awards) ceremony will be held for the 6th time on the opening day of the 13th International Drug Chemistry Conference, scheduled for Thursday, February 6, 2025.
On behalf of the 13th International Drug Chemistry Conference family, we extend our heartfelt congratulations to the award-winning companies and look forward to welcoming you at the opening ceremony to receive your awards.
The awards have been determined across eight categories. The first two categories are special awards designated by the Organizing Committee of the Conference, while the other six categories are based on the 2023 R&D Centers Data published by Turkishtime (*https://turkishtimedergi.com/arge250/). The categories and the names of the award-winning pharmaceutical companies are listed below.
New Initiative: Recognizing Excellence in Industry Scientific Publications
To emphasize the pharmaceutical industry’s contributions to science and its role in driving innovation, the Congress Organizing Committee is proud to introduce a new category in the Crystal Mortar Awards, honoring outstanding scientific publications by pharmaceutical industry. Winners will be announced on the website on January 20, 2025.
Award Criteria:
- Publications must be authored or co-authored by pharmaceutical industry professionals.
- Evaluations will consider the journal’s impact factor (based on Web of Science: https://wos-journal.info/) and the publication’s relevance and contribution to scientific and technological advancements.
- Eligible publications must have been published between 2023–2024.
- Each company’s best publication will be evaluated.
- A company can receive only one award in this category.
- The top three companies meeting the criteria will be recognized.
Submission Details:
To submit your publication for consideration, please complete the required form and submit it by January 15, 2025.
Let us celebrate the remarkable achievements of industry researchers and inspire continued excellence in scientific innovation!
Crystal Mortar Award 2025-Winners
Active Pharmaceutical Ingredient (API) Manufacturers (Congress Special Award, in alphabetical order)
ATABAY Kimya San. ve Tic. A.Ş.
DEVA Holding A.Ş.
POLİFARMA İlaç San. ve Tic. A.Ş.
ULKAR Kimya San. ve Tic. A.Ş.
Pharmaceutical Industry Scientific Publications
1. DEVA Holding A.Ş. (Q1, IF 5.6, https://doi.org/10.1016/j.talanta.2024.126510)
2. ABDİ İBRAHİM İlaç San. ve Tic. A.Ş. (Q2, IF 3.7, https://doi.org/10.1021/acsomega.4c02161)
2. WORLD MEDICINE İlaç San. ve Tic. A.Ş. (Q2, IF 3.7, https://doi.org/10.1016/j.xphs.2024.01.011)
3. ATABAY Kimya San. ve Tic. A.Ş. (Q2, IF 3.1, https://doi.org/10.1016/j.jpba.2022.115123)
4. Altium Int. Laboratuvar Cihazları A.Ş. (formerly SEM) (Q2, IF 2.8, https://doi.org/10.1016/j.jchromb.2023.123593)
2023 Pharmaceutical R&D Expenditures*
- DEVA Holding A.Ş.
- ABDİ İBRAHİM İlaç San. ve Tic. A.Ş.
- NOBEL İlaç San. ve Tic. A.Ş.
2023 Pharmaceutical R&D Number of Projects*
- WORLD MEDICINE İlaç San. ve Tic. A.Ş.
- ARGİS İlaç San. ve Tic. A.Ş.
- DEVA Holding A.Ş.
2023 Pharmaceutical R&D Total and Female Personnel Numbers*
- DEVA Holding A.Ş.
- ABDİ İBRAHİM İlaç San. ve Tic. A.Ş.
- NOBEL İlaç San. ve Tic. A.Ş.
2023 Pharmaceutical R&D Number of Personnel with MSc & PhD Degrees*
- DEVA Holding A.Ş.
- ABDİ İBRAHİM İlaç San. ve Tic. A.Ş.
- WORLD MEDICINE İlaç San. ve Tic. A.Ş.
2023 Pharmaceutical R&D Number of National Patents*
- WORLD MEDICINE İlaç San. ve Tic. A.Ş. & İLKO İlaç San. ve Tic. A.Ş. (4 patents)
- HEKTAŞ Ticaret Türk A.Ş. & SANTA FARMA İlaç San. A.Ş. (3 patents)
2023 Pharmaceutical R&D Number of Brands*
- ALİ RAİF İlaç San. A.Ş.
- SANOVEL İlaç San. Tic. A.Ş.
- HEKTAŞ Ticaret Türk A.Ş.
For inquiries, please contact us at iletisim@ilackongresi.org.